Raynald A. Samoa

Raynald Samoa practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Raynald Samoa's NPI, 1629194048, was assigned on March 21, 2007. Raynald Samoa graduated from University Of Washington School Of Medicine in 1999. Raynald Samoa holds California license A74927.

Raynald Samoa's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Raynald Samoa's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Raynald Samoa is also affiliated with San Antonio Regional Hospital. The medical group on file is City of Hope. Dmand AI also links Raynald Samoa to 1 more hospital, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Raynald Samoa practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Raynald Samoa's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Raynald Samoa is licensed in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, osteoporosis and overactive thyroid among the conditions Raynald Samoa treats.

CMS data shows 961 Medicare services from Raynald Samoa across 8 procedure codes in 2024, for 490 Medicare patients. Medicare paid $78,821 for them.

CMS counts 490 Medicare patients who saw Raynald Samoa in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Raynald Samoa's median patient age at 64, with 57% women.

In 2024, Raynald Samoa wrote 2,593 Medicare Part D claims for 276 patients. 52% of them were for generic drugs. CMS names the drug for 2,227 of them, across 60 drugs with 11 or more claims each, at $696,586 in total drug cost. In 2023, CMS named 1,733 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Raynald Samoa for performance year 2024, reported as part of a group. Raynald Samoa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Raynald Samoa as offering telehealth.

CMS Open Payments shows 55 general payments to Raynald Samoa from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,251.

Raynald Samoa graduated from University Of Washington School Of Medicine in 1999.

Raynald Samoa is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.